Lapka D M, Wild L D, Barbour L A
Division of Surgical Oncology, University of Illinois, Chicago Specialized Cancer Center.
Oncol Nurs Forum. 1994 Jun;21(5):871-6.
PURPOSE/OBJECTIVES: To describe the mechanisms and nursing care associated with heparin-induced thrombocytopenia and thrombosis (HITT).
Published books and journal articles as well as clinical experience.
HITT is an immune reaction that occurs in 1%-10% of individuals receiving heparin therapy. Characterized by a sudden drop in platelets, it can result in life-threatening hemorrhage and thrombus-related events.
Heparin commonly is used in many oncology treatment settings. Awareness of this potentially serious complication and knowledge of its treatment is critical to safe administration.
Astute assessment skills are the key to diagnosis and treatment of HITT.
目的/目标：描述肝素诱导的血小板减少症和血栓形成（HITT）的机制及护理。
已出版的书籍、期刊文章以及临床经验。
HITT是一种免疫反应，发生于1% - 10%接受肝素治疗的个体中。其特征为血小板突然减少，可导致危及生命的出血和血栓相关事件。
肝素常用于多种肿瘤治疗环境中。认识到这种潜在的严重并发症及其治疗知识对于安全用药至关重要。
敏锐的评估技能是HITT诊断和治疗的关键。
